TussiCaps (VALEANT PHARMACEUTICALS NORTH AMERICA LLC)
Welcome to the PulseAid listing for the TussiCaps drug offered from VALEANT PHARMACEUTICALS NORTH AMERICA LLC. This Opioid Agonist [EPC],Opioid Agonists [MoA],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | VALEANT PHARMACEUTICALS NORTH AMERICA LLC |
| NON-PROPRIETARY NAME: | hydrocodone polistirex and chlorpheniramine polistirex |
| SUBSTANCE NAME: | HYDROCODONE; CHLORPHENIRAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Opioid Agonist [EPC],Opioid Agonists [MoA],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-09-02 |
| END MARKETING DATE: | 0000-00-00 |
TussiCaps HUMAN PRESCRIPTION DRUG Details:
| Item Description | TussiCaps from VALEANT PHARMACEUTICALS NORTH AMERICA LLC |
| LABELER NAME: | VALEANT PHARMACEUTICALS NORTH AMERICA LLC |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 5; 4(mg/1; mg/1) |
| START MARKETING DATE: | 2011-09-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0187-0054_c60aecd2-eb62-4749-b259-be660a2439c8 |
| PRODUCT NDC: | 0187-0054 |
| APPLICATION NUMBER: | ANDA077273 |
Other HYDROCODONE; CHLORPHENIRAMINE Pharmaceutical Manufacturers / Labelers:
